Person: REZVANİ, AYLİN
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Organizational Unit
Job Title
Last Name
REZVANİ
First Name
AYLİN
Name
35 results
Search Results
Now showing 1 - 10 of 35
- PublicationMetadata onlyNephrolithiasis in ankylosing spondylitis and its relationship with disease assessment scales(2019-01-01T00:00:00Z) REZVANİ, AYLİN; Aktas, Ilknur; TAŞTEKİN, NURETTİN; Celiker, Reyhan; SARIKAYA, SELDA; DURSUN, ERBİL; ÖZDOLAP, ŞENAY; DURSUN, NİGAR; ZATERİ, COŞKUN; ALTAN İNCEOĞLU, LALE; BİRTANE, MURAT; Akgun, Kenan; SÜT, NECDET; REZVANİ, AYLİNOBJECTIVE: The aim of this study was to investigate the frequency of renal calculi in patients with ankylosing spondylitis (AS) and to determine its relationship with disease assessment variables.
- PublicationMetadata onlyThe correlation between cardiovascular risk and functional disability and disease activity in patients with rheumatoid arthritis(2013-01-01T00:00:00Z) Guler, Mustafa; Umut, Saadet Yazgan; AYDIN, Teoman; REZVANİ, AYLİN; Poyraz, Emine; AYDIN, TEOMAN; REZVANİ, AYLİNAim: To determine the cardiovascular risk (CVR) in patients with rheumatoid arthritis (RA) and its correlation with disease activity and functional ability by using the Framingham risk score (FRS) and to compare the CVR of the RA patients with the control group with the help of the FRS.
- PublicationMetadata onlyTHE FACTORS ASSOCIATED WITH DEPRESSION, ANXIETY AND ILLNESS PERCEPTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS(2012-02-01T00:00:00Z) REZVANİ, AYLİN; Demir, Saliha Eroglu; Ozaras, Nihal; Poyraz, Emine; Guneser, Meryem; REZVANİ, AYLİN
- PublicationOpen AccessInfluence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis.(2016-08-01) AKARıRMAK, Ü; KOÇYIĞIT, H; ESKIYURT, N; ESMAEILZADEH, S; KURU, Ö; YALÇINKAYA, EY; PEKER, Ö; EKIM, AA; ÖZGIRGIN, N; ÇALıŞ, M; Rezvani, AYLİN; ÇEVIKOL, A; EYIGÖR, S; ŞENDUR, ÖF; İRDESEL, J; INSTRUCT, Study; REZVANİ, AYLİNObjective: In our study, we aimed to evaluate the influence of training on compliance and persistence with bisphosphonate treatment given on a weekly vs. monthly basis in postmenopausal osteoporosis patients. Methods: A total of 979 patients with postmenopausal osteoporosis (mean age: 63.2 ± 7.2 years) were included in this national, multicenter, prospective non-interventional observational cohort registry study. Patients were randomized into training (n ¼ 492, 50.3%, mean age: 63.4 ± 7.2 years) and control (n ¼ 487, 49.7%, mean age: 63.0 ± 7.1 years) groups. Patients in each intervention group were given weekly (44.9% and 44.6% for training and control subjects, respectively) or monthly (55.1% and 55.4%, respectively) bisphosphonate regimens. After the initial visit, patients were followed up at three-month intervals throughout 12 months of treatment for evaluation of persistence, compliance and adverse events. Results: On average, 79.4% of the patients were persistent with the treatment with a mean of 350.4 days of duration during the 12-month follow-up period. The mean compliance in the compliant and fully compliant group remained at an average of 86.6%. No significant difference was detected between the training and control groups in terms of compliance and persistence. Significantly longer persistence (360.0 ± 89.0 vs. 345.0 ± 108.0 days; p ¼ 0.035), higher percentage of persistent patients (83.4% vs. 74.2%; p ¼ 0.012) and higher compliance rates (88.8% vs. 83.3%; p ¼ 0.002) were noted in monthly regimen patients in comparison to those given weekly regimen. Conclusion: Our findings revealed remarkably high rates for persistence and compliance with bisphosphonate treatment in postmenopausal osteoporosis, with no impact of training on compliance and persistence rates. Longer persistence and better compliance rates were achieved with the monthly bisphosphonate regimen when compared to the weekly regimen.
- PublicationOpen AccessThe relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population(2016-01-01) OZKAYA, Dilek Biyik; Onsun, NAHİDE; Su, Ozlem; Bahali, ANIL GÜLSEL; Dizman, DİDEM; Rezvani, AYLİN; Uysal, Omer; ONSUN, NAHIDE; SU KÜÇÜK, ÖZLEM; BAHALI, ANIL GÜLSEL; DİZMAN, DİDEM; REZVANİ, AYLİN; UYSAL, ÖMERIntroduction: Psoriasis is a chronic, immune-mediated inflammatory disease predominantly affecting the skin, with a complex aetiology. Recently it has been suggested that the chronic inflammation of psoriasis may cause metabolic and vascular disorders. The relationship between obesity and psoriatic arthritis (PsA) is not clear, and there are insufficient prospective studies addressing this subject. Aim: To investigate the relationship between psoriatic arthritis, severity of psoriasis and obesity in the Turkish population. Material and methods: Patient data from psoriasis outpatient clinics from February 2007 to July 2013 were reviewed retrospectively using the Psoriasis-Turkey (PSR-TR) registration system. Patients' age, onset age, body mass index (BMI), waist circumference, psoriasis area and severity index (PASI), and arthritis information were reviewed. In the outpatient clinics, patients who had joint pain consulted rheumatology clinics. The CASPAR criteria were used for the diagnosis of arthritis. Results: A total of 443 males and 495 females enrolled in this study. The mean age of females was 43.9 years (18-93 years) and the mean age of males was 44.6 years (18-89 years). A total of 231 (25%) patients had psoriatic arthritis. Investigation of the relationship between PASI, BMI, waist circumference (WC) and arthritis revealed a statistically significant relationship between each variable. Conclusions: In this study we observed a relationship between PsA and high BMI, high WC and high PASI. Psoriatic arthritis is a chronic inflammatory disorder and a chronic inflammatory state induced by adiposity may lead to PsA.
- PublicationOpen AccessCan ultrasound be an assessment tool for sagittal spine mobility and chest expansion in patients with ankylosing spondylitis?(2018-09-01T00:00:00Z) Yurdakul, OZAN VOLKAN; REZVANI, AYLİN; YURDAKUL, OZAN VOLKAN; REZVANİ, AYLİN
- PublicationMetadata onlyThe Effects of Tumor Necrosis Factor Alpha Inhibition on Apoptotic Cell Death In B-Cell with Type-I Diabetes-Induced by Streptozotocin(2016-09-01T00:00:00Z) Guven, Celal; Guven, Eylem Taskin; Yazgan, Pelin; REZVANİ, AYLİN; KOCAHAN, SAYAD; REZVANİ, AYLİN
- PublicationMetadata onlyWorsening of Psoriatic Arthritis After Ustekinumab Treatment.(2018-05-01) Onsun, NAHİDE; YALCIN, BURAK; SALLAHOGLU, K; REZVANI, AYLİN; ONSUN, NAHIDE; YALÇIN, BURAK; REZVANİ, AYLİN
- PublicationMetadata onlyThe Disease Course in Daily Clinical Practice in Radiographic and Non-Radiographic Axial Spondyloarthritis Patients; One-Year Follow-up Results of National-Subgroup of a Worldwide Observational Cohort Study(2017-10-01T00:00:00Z) AKAR, SERVET; Sezer, Ilhan; Yumusakhuylu, Yasemin; AKINCI, AYŞEN; Erol, Kemal; Akgun, Kenan; Bodur, Hatice; Ataman, Sebnem; Kuru, Omer; ALKAN MELİKOĞLU, Meltem; KARKUCAK, MURAT; Bugdayci, Nazli Derya; Bakirli, Duygu Ersozlu; BİRTANE, MURAT; Duruoz, Tuncay; ERTEN, ŞÜKRAN; Dalkilic, Ediz; KINIKLI, GÜLAY; Bes, Cemal; Omma, Ahmet; REZVANİ, AYLİN; REZVANİ, AYLİN
- PublicationOpen AccessSEXUAL FUNCTIONS IN MALE WITH ANKYLOSING SPONDYLITIS(2012-02-01T00:00:00Z) REZVANİ, AYLİN; Seniz, Ok; Demir, Saliha Eroglu; REZVANİ, AYLİN